Glycosylation as a key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2

The emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its spread since 2019 represents the major public health problem worldwide nowadays, generating a high number of infections and deaths. That’s why, in addition to vaccination campaigns, the design of a drug to help...

Descripción completa

Guardado en:
Autores principales: Georcki Ropón‐Palacios, Jhon Pérez-Silva, Ricardo Rojas-Humpire, Gustavo E. Olivos-Ramírez, Manuel Enrique Chenet Zuta, Víctor Villanueva, Sheyla Carmen-Sifuentes, Kewin Otazu, Yaritza L. Ramirez-Díaz, Ihosvany Camps
Formato: Preprint
Lenguaje:inglés
Publicado: 2021
Materias:
Glycosylation
Glycoprotein
Computational biology
Drug
Biology
Protein folding
Chemistry
Cell biology
Virology
Genetics
Pharmacology
Health Sciences Medicine Infectious Diseases SARS-CoV-2 and COVID-19 Research
Life Sciences Biochemistry, Genetics and Molecular Biology Molecular Biology vaccines and immunoinformatics approaches
Health Sciences Medicine Radiology, Nuclear Medicine and Imaging Monoclonal and Polyclonal Antibodies Research
Acceso en línea:Descargar el archivo
Enlace permanente (DOI o Handle)
Enlace permanente (DOI o Handle)
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares: Glycosylation as a key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2

Ejemplares similares